Clinical trial
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment…
NCT00430937 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00430937 |
|---|---|
| Title | Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections |
| Official title | A Multicenter, Randomized, Assessor-Blind Study to Evaluate Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (cSSTI) |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Skin Diseases, Infectious, Soft Tissue Infections |
| Intervention type | Drug |
| Interventions | Daptomycin, Vancomycin, Teicoplanin |
| Enrollment | 194 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2008 |
| First posted | Feb 2, 2007 |
| Last update posted | Jul 16, 2012 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: